1-Phenylpiperazine Dihydrochloride - CAS 4004-95-9
Catalog: |
BB024265 |
Product Name: |
1-Phenylpiperazine Dihydrochloride |
CAS: |
4004-95-9 |
Synonyms: |
1-phenylpiperazine;dihydrochloride; 1-phenylpiperazine;dihydrochloride |
IUPAC Name: | 1-phenylpiperazine;dihydrochloride |
Description: | 1-Phenylpiperazine was tested for its activity as a topical glaucoma agent. |
Molecular Weight: | 235.15 |
Molecular Formula: | C10H16Cl2N2 |
Canonical SMILES: | C1CN(CCN1)C2=CC=CC=C2.Cl.Cl |
InChI: | InChI=1S/C10H14N2.2ClH/c1-2-4-10(5-3-1)12-8-6-11-7-9-12;;/h1-5,11H,6-9H2;2*1H |
InChI Key: | CUTPTQNQXVVRDB-UHFFFAOYSA-N |
Boiling Point: | 287.2 °C at 760 mmHg |
LogP: | 2.29200 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
JP-2015536914-A | Substituted phenyl carbamate compounds | 20121012 |
CN-101137645-A | Aryl piperazine derivatives for the treatment of neuropsychiatric disorders | 20050103 |
KR-20070057931-A | 6- (Pyridinyl) -4-pyrimidone derivatives as tau protein kinase 1 inhibitors | 20040929 |
AU-2005244389-A1 | 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2H-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders | 20040511 |
AU-2005244389-B2 | 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2H-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders | 20040511 |
PMID | Publication Date | Title | Journal |
22960444 | 20121201 | Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats | Neuropharmacology |
22864394 | 20121001 | DNA-binding, spectroscopic and antimicrobial studies of palladium(II) complexes containing 2,2'-bipyridine and 1-phenylpiperazine | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
22957817 | 20121001 | Phenylpiperazine derivatives: a patent review (2006 - present) | Expert opinion on therapeutic patents |
22381672 | 20120401 | Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities | Bioorganic & medicinal chemistry |
22225603 | 20120301 | FT-IR and Raman spectroscopic and quantum chemical investigations of some metal halide complexes of 1-phenylpiperazine | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
Complexity: | 124 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 3 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 234.0690539 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 234.0690539 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 15.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS